Valuation
- Market cap
- 4,097,000
- Revenue TTM
- $0
- Net income TTM
- $-18,260,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.42
Trading
- Volume
- 9,395,600
- Avg volume
- 1,770,942
- Day's range
- $0.26 – $0.31
- Shares out
- 14,527,000
- Stochastic %K
- 57%
- Beta
- -0.03
- Analysts
- Strong Buy
- Price target
- —
Company profile
Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and softwa...
Show more
Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.
- Industry
- Real Estate Services
- Sector
- Real Estate
- Phone
- 732 780 4400
- Website
- https://www.avalon-globocare.com
- Address
- 4400 Route 9 South, Suite 3100, Freehold, United States
Latest news
No headlines yet.
